Back to Search
Start Over
Estrogen Replacement Therapy Induces Antioxidant and Longevity-Related Genes in Women after Medically Induced Menopause.
- Source :
-
Oxidative medicine and cellular longevity [Oxid Med Cell Longev] 2021 Sep 09; Vol. 2021, pp. 8101615. Date of Electronic Publication: 2021 Sep 09 (Print Publication: 2021). - Publication Year :
- 2021
-
Abstract
- Females live longer than males in many species, including humans, and estrogens are in part responsible for this protection against aging. We reported previously that estrogens can protect rats against oxidative stress, by inducing antioxidant and longevity-related genes. Thus, this study was aimed at confirming the ability of estrogens to upregulate antioxidant and longevity-related genes in humans. For this purpose, we selected 16 women of reproductive age (18-42 years old) undergoing a fertility treatment that includes a medically induced menopause, at the Valencian Infertility Institute. We took blood samples at each time point of the treatment (basal, induced menopause, estrogen, and estrogen plus progesterone replacement therapy). mRNA expression of antioxidant and longevity-related genes in peripheral blood mononuclear cells (PBMC) was determined by real-time reverse transcriptase-polymerase chain reaction (RT-PCR). Determination of reduced glutathione (GSH) in total blood was carried out using high-performance liquid chromatography (HPLC). As expected, we found that medically induced menopause significantly decreased sexual hormone (estrogens and progesterone) levels. It also lowered glutathione peroxidase (GPx), 16S rRNA, P21, and TERF2 mRNA expression and blood GSH levels. Estrogen replacement therapy significantly restored estrogen levels and induced mRNA expression of manganese superoxide dismutase (MnSOD), GPx, 16S rRNA, P53, P21, and TERF2 and restored blood GSH levels. Progesterone replacement therapy induced a significant increase in MnSOD, P53, sestrin 2 (SENS2), and TERF2 mRNA expression when compared to basal conditions. These findings provide evidence for estrogen beneficial effects in upregulating antioxidant and longevity-related genes in women.<br />Competing Interests: The authors declare that they have no financial/commercial conflict of interests regarding the publication of this paper.<br /> (Copyright © 2021 C. Borrás et al.)
- Subjects :
- Adolescent
Adult
Estrogen Replacement Therapy methods
Estrogens blood
Female
Glutathione blood
Glutathione Peroxidase genetics
Glutathione Peroxidase metabolism
Humans
Leukocytes, Mononuclear cytology
Leukocytes, Mononuclear drug effects
Leukocytes, Mononuclear metabolism
Progesterone blood
RNA, Ribosomal, 16S genetics
RNA, Ribosomal, 16S metabolism
Superoxide Dismutase genetics
Superoxide Dismutase metabolism
Telomeric Repeat Binding Protein 2 genetics
Telomeric Repeat Binding Protein 2 metabolism
Up-Regulation drug effects
Young Adult
Antioxidants metabolism
Estradiol administration & dosage
Longevity genetics
Menopause drug effects
Triptorelin Pamoate pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1942-0994
- Volume :
- 2021
- Database :
- MEDLINE
- Journal :
- Oxidative medicine and cellular longevity
- Publication Type :
- Academic Journal
- Accession number :
- 34539974
- Full Text :
- https://doi.org/10.1155/2021/8101615